Secretome from human adipose-derived mesenchymal stem cells promotes blood vessel formation and pericyte coverage in experimental skin repair.
Brysa M SilveiraTiago O RibeiroRailane S FreitasAna Claudia Oliveira CarreiraMarilda Souza GonçalvesMari SogayarRoberto MeyerAlexander BirbrairVitor FortunaPublished in: PloS one (2022)
Human adipose tissue-derived stem cells (hASC) secretome display various therapeutically relevant effects in regenerative medicine, such as induction of angiogenesis and tissue repair. The benefits of hASC secretome are primarily orchestrated by trophic factors that mediate autocrine and paracrine effects in host cells. However, the composition and the innate characteristics of hASC secretome can be highly variable depending on the culture conditions. Here, we evaluated the combined effect of serum-free media and hypoxia preconditioning on the hASCs secretome composition and biological effects on angiogenesis and wound healing. The hASCs were cultured in serum-free media under normoxic (NCM) or hypoxic (HCM) preconditioning. The proteomic profile showed that pro- and anti-antiangiogenic factors were detected in NCM and HCM secretomes. In vitro studies demonstrated that hASCs secretomes enhanced endothelial proliferation, survival, migration, in vitro tube formation, and in vivo Matrigel plug angiogenesis. In a full-thickness skin-wound mouse model, injection of either NCM or HCM significantly accelerated the wound healing. Finally, hASC secretomes were potent in increasing endothelial density and vascular coverage of resident pericytes expressing NG2 and nestin to the lesion site, potentially contributing to blood vessel maturation. Overall, our data suggest that serum-free media or hypoxic preconditioning enhances the vascular regenerative effects of hASC secretome in a preclinical wound healing model.
Keyphrases
- wound healing
- endothelial cells
- stem cells
- adipose tissue
- mouse model
- ischemia reperfusion injury
- hypertrophic cardiomyopathy
- immune response
- vascular endothelial growth factor
- cell therapy
- insulin resistance
- induced apoptosis
- cerebral ischemia
- blood brain barrier
- mesenchymal stem cells
- signaling pathway
- metabolic syndrome
- cell proliferation
- optical coherence tomography
- machine learning
- big data
- atrial fibrillation
- affordable care act
- type diabetes
- subarachnoid hemorrhage
- artificial intelligence
- health insurance
- free survival